Aster DM Healthcare ties-up with Dr. Reddy’s Laboratories to administer Sputnik V vaccine for a limited pilot soft launch

~The partnership encompasses vaccination of beneficiaries in (Kochi) Kerala

and Kolhapur (Maharashtra)~

New Delhi, 18 June 2021: Aster DM Healthcarae, an emerging healthcare player in India has partnered with Dr. Reddy's Laboratories to administer the Sputnik V Vaccine as part of a limited pilot soft launch.  To help bolster the vaccine implementation drive by the Government of India, Aster DM Healthcare will initially inoculate beneficiaries in (Kochi) Kerala and Kolhapur (Maharashtra) through Aster Medcity, Kochi and Aster Aadhar, Kolhapur hospitals.

At Aster, over a hundred credentialed staff have been trained at the 14 hospitals spread across the country. Beneficiary protocols have been established as per Standard Operating Procedures recommended by the Government which includes registration, waiting area allocation along with patient education & awareness displays and post-vaccination observation. Trained medical staff along with emergency care support, will be stationed to administer appropriate care in case of an adverse event.

Dr. Reddy’s has facilitated the necessary cold storage infrastructure for vaccine storage at the hospitals.

Speaking about the association, Dr Harish Pillai, CEO- Aster India, Aster DM Healthcare, said, “We are pleased to collaborate with Dr. Reddy’s Labs to administer the Sputnik V Vaccine, through its pilot program and are certain that it will further accelerate the overall vaccination drive. We look forward to building a strong partnership with Dr. Reddy’s across our network of hospitals to further strengthen our efforts in providing easy access and vaccinating the community”.

Commenting on the alliance, M.V. Ramana, CEO – Branded Markets (India & Emerging Markets), Dr. Reddy’s, said: “We are pleased to collaborate with Aster DM Healthcare in Kochi and Kolhapur as we scale up our soft pilot launch of the Sputnik V vaccine in India to more cities ahead of its commercial launch. In the upcoming months, we hope to inoculate as many Indians as possible.”

About Aster DM Healthcare

Aster DM Healthcare Limited is one of the largest integrated healthcare service providers operating in GCC and an emerging healthcare player in India. With an inherent emphasis on clinical excellence, we are one of the few entities in the world with a strong presence across primary, secondary, tertiary and quaternary healthcare through our 27 hospitals, 115 clinics and 225 pharmacies. We have over 21,000 plus dedicated employees including 2887 doctors and 6283 nurses across the geographies that we are present in, delivering a simple yet strong promise to our different stakeholders: “We’ll treat you well.” We cater to all economic segments of the society through our three brands: Aster, Access and Medcare. For more information, please visit www.asterdmhealthcare.com.

About Dr. Reddy’s

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) is an integrated pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services & Active Ingredients, Global Generics and Proprietary Products – Dr. Reddy’s offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars and differentiated formulations. Our major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Dr. Reddy’s operates in markets across the globe. Our major markets include – USA, India, Russia & CIS countries, and Europe. For more information, log on to: www.drreddys.com